Clinical Trials on Barotitis

Total 47 results

Mansoura University

Unknown

Gender and Opioid Consumption (GenderOpioid)

Postoperative; Parotitis
University of Calgary

Recruiting

Efficacy of Balloon Dilation of the Eustachian Tube in Eustachian Tube Dilatory Dysfunction

Eustachian Tube Dysfunction | Barotitis

Canada
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11

Epidemic Parotitis, Mumps

China
Carmel Medical Center

Not yet recruiting

Treatment of Juvenile Recurrent Parotitis: the Yield of Minimally Invasive Intervention (JRP)

Parotitis, Juvenile Recurrent

Israel
Centre Hospitalier Universitaire, Amiens

Unknown

Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria

Retroperitoneal Fibrosis | Idiopathic Aortitis

France
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Epidemic Parotitis,Mumps

China
Northwell Health

Enrolling by invitation

Diagnostic Precision and Accuracy Using the Teed Scoring System Versus the O'Neill Grading System (OGS)

Pressure Injury | Barotrauma | Otic Barotrauma | Ear Injury | Barotitis

United States
University of Pennsylvania
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

VCRC Longitudinal Protocol for Aortitis

Aortitis

United States, Canada
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old

Mumps

China
Institute of Medical Biology, Chinese Academy of...
Hebei Provincial Center for Diseases Control and Prevention

Completed

A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Mumps

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Mumps

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sri Edupuganti, MD MPH
Merck Sharp & Dohme LLC

Completed

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Measles | Rubella | Mumps

United States
GlaxoSmithKline
Parexel

Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Measles | Rubella | Mumps

United States, Slovakia, Estonia
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations (MMR)

Measles | Rubella | Mumps

Brazil
Merck Sharp & Dohme LLC

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Jiangsu Province Centers for Disease Control and...

Completed

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

Fever | Parotid Gland Infection

China
The Immunobiological Technology Institute (Bio-Manguinhos)...
GlaxoSmithKline

Completed

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Measles | Rubella | Mumps | Varicella

Brazil
University of Michigan

Completed

Making Decisions About the Measles-Mumps-Rubella Vaccine

Measles | Rubella | Mumps | MMR Vaccination

United States
University of Zurich
Merck Sharp & Dohme LLC

Recruiting

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination (MIPS)

Measles | Rubella | Mumps

Switzerland
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

Measles | Rubella | Mumps

Brazil
Sinovac Biotech Co., Ltd

Active, not recruiting

The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students

Mumps | Influenza

China
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Measles-Mumps-Rubella

Taiwan, United States, Korea, Republic of
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

Measles | Hepatitis A | Rubella | Mumps

Turkey
GlaxoSmithKline

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Measles | Rubella | Mumps | Varicella

Germany, Italy, France
Merck Sharp & Dohme LLC

Completed

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Measles | Rubella | Mumps | Varicella

Canada, Italy
GlaxoSmithKline

Withdrawn

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Measles | Rubella | Mumps | Varicella

India
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Measles | Rubella | Mumps | Varicella

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Belgium, Germany, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Finland, Germany, Poland, Greece
GlaxoSmithKline

Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Measles | Rubella | Mumps | Varicella

Germany, Austria
Sanofi Pasteur, a Sanofi Company

Completed

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Japanese Encephalitis | Measles | Rubella | Mumps

Taiwan
Zhejiang Provincial Center for Disease Control...

Active, not recruiting

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Measles | Rubella | Mumps | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18

China
GMIOFrance

Not yet recruiting

TocILizumab in aorTitis in GCA (TILT) (TILT)

Giant Cell Arteritis | Aortitis
Liaoning Chengda Biotechnology CO., LTD

Recruiting

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Japanese Encephalitis | Measles | Rubella | Mumps

China
PATH
Syneos Health; Research Institute for Tropical Medicine; DF/Net Research, Inc.

Completed

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Encephalitis, Japanese | Measles | Rubella | Mumps

Philippines
The Cleveland Clinic
GE Healthcare

Completed

Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis

Vasculitis | Giant Cell Arteritis | Arteritis | Takayasu's Arteritis | Aortitis

United States
University of Pennsylvania
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Recruiting

VCRC Tissue Repository

Giant Cell Arteritis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis Nodosa | Eosinophilic Granulomatosis With Polyangiitis | Henoch-Schonlein Purpura | Takayasu Arteritis | Aortitis | IgA Vasculitis | Granulomatosis With Polyangiitis (Wegener's) | Cutaneous Vasculitis

United States, Canada

Clinical Trials on Barotitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations